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Preface
The power of metabolism — Linking energy supply and demand with cardiac contractile
function☆
Every type of motion requires some sort of energy. In the living
world as we know it, this energy is provided by the consumption of
nutrients in particular carbohydrates, fatty acids and amino acids. The
energy contained within these substrates is converted by metabolic
processes into motion and heat. It is therefore no surprise that in-
vestigations of biological processes in health and disease often directly
contain or end up with recognitions or questions in the field of meta-
bolism. The heart is the most active muscle in mammals with a con-
traction every second throughout life. Thus, cardiac motion seems the
most constant motion known. To support life, the mammalian heart
must contract incessantly. As a consequence, the requirement for en-
ergy (in the form of ATP) to fuel this function is immense. Interestingly,
high energy phosphate storage within the cardiomyocyte is minimal
and may support contraction only for a few beats i.e. a few seconds.
Thus, tight coupling between substrate conversion into ATP and myo-
cardial contraction is essential for normal cardiac function. This has led
to the elegant suggestion of a direct and reversible interrelationship
between contractile function and metabolic activity as shown on the
cover of this issue [1]. Thus, metabolic activity is not simply dictated by
contractile activity. In contrast, it may also be used to influence con-
tractile function and therefore overall cardiac performance. The latter
recognition is the base for metabolic therapy of diseases such as dia-
betes or heart failure. This link between energy metabolism and con-
tractile function was the focus of the meeting of the Society for Heart
and Vascular Metabolism 2017 in Weimar (Germany). The specific to-
pics discussed during this meeting have led to the generation of this
special issue. The following authors describe the current “state of the
art” regarding the link between metabolism and function and are
summarized as follows:
Volker Adams and his group review the impact of exercise on car-
diovascular disease and risk [2]. Exercise is a condition that sig-
nificantly affects metabolic activity of the organism. Currently it is also
clear that exercise affects human health. Again, this change in meta-
bolic activity appears to offer significant therapeutic potential which
has not been used to full capacity. They present that with respect to
exercise in cardiovascular disease, many concepts have changed and
even patients with myocardial infarction are nowadays included into
exercise training programs very shortly after the insult.
Exercise intolerance is a frequent condition in heart failure with
reduced ejection fraction. Linda Peterson and her group present in their
manuscript an overview on the effects of inorganic nitrate on exercise
capacity in patients [3]. They indicate why inorganic nitrate has
advantages over other sources of NO. Furthermore, they present the
mechanisms of action of NO relating to improved exercise performance
in heart failure. While there is a larger trial underway, the presented
effects may be interesting to follow as they together with the impact of
exercise training reported by Volker Adams [2] suggest an intensified
effect of exercise therapy in heart failure patients.
The mechanisms for exercise effects on cardiovascular health are
still far from clear. Instead, it is known that exercise capacity depends
on coupling of ATP generation and contraction in both skeletal muscles
and the heart. Central to the coordinated energy transduction function
is the mitochondrion. Mitochondria generate not only more than 95%
of ATP but also regulate intracellular calcium homeostasis, signaling
and cell death. Thus mitochondrial function is of major importance but
there are yet limited possibilities to investigate mitochondrial function
in vivo. In the manuscript of Vera Schrauwen and her group the current
knowledge to use magnetic resonance spectroscopy for analysis of
cardiac metabolism is discussed [4].
Sina Coldewey and her group describe a new method to assess mi-
tochondrial function in vivo in their manuscript [5]. They describe the
use of the Protoporpyhrin IX Triplett State Lifetime Technique to de-
termine mitochondrial oxygen delivery, oxygen tension as well as
oxygen consumption in vivo. The variables influencing mitochondrial
oxygen use in vivo are described in a pilot study of 26 healthy subjects
with and without exercise [5]. This investigation may pave the way for
a routine in vivo analysis of mitochondrial function.
Such in vivo analysis of mitochondrial function expected to be very
important in septic patients. Mervyn Singer and his group review the
current knowledge [6] on the role of mitochondria in sepsis. Mi-
tochondrial dysfunction has been suggested as a discriminator between
survival and death. Importantly, an early analysis in sepsis is indis-
pensable as sepsis rapidly worsens and treatment has to be immediate.
Mitochondrial dysfunction has been suggested to contribute to sepsis
induced cardiomyopathy as metabolic derangements are central in this
disease. The authors describe the pathophysiology underlying myo-
cardial dysfunction in sepsis and focus in their manuscript on mi-
tochondrial processes. The analysis of metabolism and mitochondrial
function and preservation of mitochondrial integrity and quality may
be a basis for improved treatment in the future.
The second manuscript of Sina Coldewey and her group [7] ad-
dresses AMPK signaling in sepsis. This contribution is of interest be-
cause sphingosine-1-phosphate signaling in some endothelial cells is
mediated by the well-known metabolic sensor AMPK and thereby
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mediates stabilization of the endothelial barrier. In sepsis, breakdown
of endothelial barrier is critical for organ failure and endothelial sta-
bilization may thus prevent death. Whether sphingosine-1-phosphate
signaling on AMPK affects substrate metabolism simultaneously re-
mains an interesting question in this situation, but may have a high
potential to explain metabolic changes in sepsis.
Naturally, mitochondria as the hotspot for ATP generation and
substrate use attract further attention in metabolic research. Thus, the
article of Yan Burelle and his group [8] presents an overview on mi-
tochondrial quality control pathways. The authors indicate that mi-
tochondrial quality control relies on multiple overlapping mechanisms.
Mitochondrial proteases and chaperones process newly imported pro-
teins but degrade non-assembled proteins as well. Protease involvement
in mitochondrial unfolded protein response is discussed. Similarly, the
ubiquitine-proteasome pathway and mitochondrial dynamics are pre-
sented as important quality control mechanisms in mitochondria. Mi-
tochondria derived vesicles as new pathway for quality control is dis-
cussed and last but not least mitophagy is presented as well.
Mitophagy pathways are reviewed in detail by Åsa Gustafsson and
her group [9]. Canonical as well as non-canonical pathways of mito-
phagy are discussed and the link of these pathways to cardiac health is
explored [9]. This important process selectively removes dysfunctional
mitochondria as they may produce high amounts of reactive oxygen
species (ROS) or induce apoptosis. The authors discuss mitochondrial
membrane dysfunction as an important component in initiating mito-
phagic processes.
Mitochondrial membranes present with unique properties due to
cardiolipin as a major component. The review of Peter Rehling and his
group [10] focuses on the role of cardiolipin in cardiac health and
disease. The role of cardiolipin in mitochondrial biogenesis as well as
morphology is addressed. Cardiolipin as the major membrane compo-
nent also affects the function of the membrane associated respiratory
chain. Furthermore, with its close proximity to places of ROS produc-
tion, cardiolipin is easily oxidized in case ROS production becomes
dysregulated, leading to changes in membrane morphology as well as
respiratory chain function.
Oxidative stress not only affects cardiolipin, but is regarded as a
main contributor to damage in ischemia and reperfusion as well as in
hypoxia. Ischemia/reperfusion is mainly seen in myocardial infarction
but is also voluntarily induced in cardiac surgery procedures. A pro-
tection of the myocardium against such damages is highly needed as
myocardial infarction is a main cause of death in western societies.
Petra Kleinbongard and her group address in their review the question
whether or not ischemic conditioning has an effect on myocardial
contractile function following an acute myocardial infarction [11].
Again, mitochondria play a major role as ischemic conditioning im-
proves respective preserves mitochondrial respiration, ATP production
and calcium handling. However, while effects on mitochondria have
been shown, the long term effects of ischemic conditioning need further
evaluation. The authors review in their manuscript the current knowl-
edge and elucidate where further investigations are needed.
In ischemia, one important signaling molecule is hypoxia signaling
factor. Maria Da Luz Sousa Fialho and coworkers [12] address the
signaling pathways of HIF and its effect on cardiac metabolism. As HIF
is one of the drivers of metabolic changes in ischemia and myocardial
infarction the authors summarize the effects of HIF signaling on uptake
of fatty acids as well as glucose and analyze the effects on the meta-
bolism of these substrates. The authors present an overview on HIF
research and HIF targeting drugs and indicate why HIF may be an at-
tractive target for therapy of cardiac disease.
A different approach to target metabolism in hypoxia is presented
by the group of Andrew Murray [13]. In their manuscript the effects of
nitrate on tissue oxygenation, fatty acid metabolism and mitochondrial
function in skeletal muscle are addressed. The authors present results
indicating that hypoxia induces impairment in mitochondrial re-
spiratory function in the soleus. This impairment was abolished when
nitrate was supplemented in drinking water and this effect was in-
dependent of PPARα signaling. Whether such effect is also present in
the heart may be an interesting question with therapeutic potential.
Another unconventional but nevertheless promising approach to
target mitochondrial dysfunction in ischemic or hypoxic conditions
may represent alternative respiratory chain enzymes. In their manu-
script Howy Jacobs and his group [14] present alternative respiratory
enzymes as a protection against external stressors. Alternative re-
spiratory enzymes represent enzymes which may replace one or several
complexes of the respiratory chain. Thereby they may offer pathways
which are not affected by inhibitors of the respiratory chain. As an
example, Ciona intestinalis alternative respiratory chain enzymes are
upregulated by hypoxia. This may reduce oxidative stress and improve
survival in this situation. Furthermore, it has been shown that these
enzymes may extend lifespan. However, alternative respiratory chain
enzymes are not known from vertebrates or drosophila. Thus, their
effect in mammals has only partially been investigated and remains a
promising field of research.
Taken together, this special issue with reviews and original con-
tributions presenting current knowledge as well as new aspects of
cardiac metabolism reflects the importance of cardiac metabolism for
contractile function. It strongly supports the view that metabolic ATP-
producing and non-ATP producing pathways may be critical regulators
of contractile function. Thus, the importance of substrate metabolism to
cardiac pump function is beyond the scope of only modulation of en-
ergy supply.
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